Arthritis critically dependent on innate immune system players.

[1]  G. Palmer.  Autoantibodies to GPI in rheumatoid arthritis , 2001 .

[2]  Randall S. Davis,et al.  Identification of a family of Fc receptor homologs with preferential B cell expression , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Gauguier,et al.  Genetic Influences on the End-Stage Effector Phase of Arthritis , 2001, The Journal of experimental medicine.

[4]  Paul M. Allen,et al.  Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis1 , 2001, The Journal of Immunology.

[5]  D. Burton,et al.  Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease , 2001, Nature Immunology.

[6]  N. Palanisamy,et al.  IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. , 2001, Immunity.

[7]  G. Nilsson,et al.  Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients , 2001, Annals of the rheumatic diseases.

[8]  J. V. Ravetch,et al.  IgG Fc receptors. , 2001, Annual review of immunology.

[9]  J. Ravetch,et al.  Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. , 2000, Immunity.

[10]  A. Vogt,et al.  Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification. , 2000, The Biochemical journal.

[11]  B. Heyman,et al.  Induction and Suppression of Collagen-Induced Arthritis Is Dependent on Distinct Fcγ Receptors , 2000, The Journal of experimental medicine.

[12]  L. Matis,et al.  A Role for Complement in Antibody-Mediated Inflammation: C5-Deficient DBA/1 Mice Are Resistant to Collagen-Induced Arthritis , 2000, The Journal of Immunology.

[13]  L. van de Putte,et al.  Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis. , 2000, Arthritis and rheumatism.

[14]  J. Martín,et al.  Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[15]  R. Schmidt,et al.  Mouse FcγRII is a negative regulator of FcγRIII in IgG immune complex‐triggered inflammation but not in autoantibody‐induced hemolysis , 2000 .

[16]  R. Misra,et al.  Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis. , 2000, Rheumatology.

[17]  H. Colten,et al.  Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B1 , 2000, The Journal of Immunology.

[18]  C. Benoist,et al.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.

[19]  F. Vivanco,et al.  The covalent interaction of C3 with IgG immune complexes. , 1999, Molecular immunology.

[20]  M. Feldmann,et al.  The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. , 1999, Journal of immunology.

[21]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[22]  K. Rajewsky,et al.  From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. , 1999, Immunity.

[23]  T. Yoshino,et al.  Deletion of Fcγ Receptor IIB Renders H-2b Mice Susceptible to Collagen-induced Arthritis , 1999, The Journal of experimental medicine.

[24]  J. Köhl,et al.  On the role of complement and Fc gamma-receptors in the Arthus reaction. , 1999, Molecular immunology.

[25]  K. Reid,et al.  Does properdin crosslink the cellular and the humoral immune response? , 1999, Immunology today.

[26]  Pier Paolo Pandolfi,et al.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.

[27]  J. Ravetch,et al.  Divergent roles for Fc receptors and complement in vivo. , 1998, Annual review of immunology.

[28]  H. Colten,et al.  Abrogation of the alternative complement pathway by targeted deletion of murine factor B. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Edwards,et al.  Restricted expression of FcγRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis (RA) , 1997, Clinical and experimental immunology.

[30]  W. Arend,et al.  The pathophysiology and treatment of rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[31]  S Askari,et al.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. , 1996, Immunity.

[32]  V. Kouskoff,et al.  Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.

[33]  W. Fridman,et al.  Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum. , 1996, Journal of immunology.

[34]  J. Ravetch,et al.  A dominant role for mast cell Fc receptors in the Arthus reaction. , 1996, Immunity.

[35]  U. Höpken,et al.  The C5a chemoattractant receptor mediates mucosal defence to infection , 1996, Nature.

[36]  R. Schmidt,et al.  Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice , 1996 .

[37]  E. Kremmer,et al.  Regulation of the B cell response to T-dependent antigens by classical pathway complement. , 1996, Journal of immunology.

[38]  R. Karr,et al.  Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Ahearn,et al.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.

[40]  M. Ono,et al.  Augmented humoral and anaphylactic responses in FcγRII-deficient mice , 1996, Nature.

[41]  P. Butko,et al.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Matis,et al.  Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Hugli,et al.  C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation , 1995, The Journal of experimental medicine.

[44]  B. Stockinger,et al.  Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen , 1994, The Journal of experimental medicine.

[45]  J. Ravetch,et al.  FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.

[46]  C. Gerard,et al.  C5A anaphylatoxin and its seven transmembrane-segment receptor. , 1994, Annual review of immunology.

[47]  Yan Zhang,et al.  Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. , 1992, Science.

[48]  R. Holmdahl,et al.  T-cell receptor V beta haplotype and complement component C5 play no significant role for the resistance to collagen-induced arthritis in the SWR mouse. , 1991, Immunology.

[49]  R. Maini,et al.  Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. , 1990, Annals of the rheumatic diseases.

[50]  K. Joiner,et al.  Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. , 1989, The Journal of clinical investigation.

[51]  F. Gervais,et al.  The C5-sufficient A/J congenic mouse strain. Inflammatory response and resistance to Listeria monocytogenes. , 1989, Journal of immunology.

[52]  John D Lambris,et al.  Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-C5 antibodies. , 1987, Molecular and Cellular Probes.

[53]  W. P. Kolb,et al.  Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments , 1983, The Journal of experimental medicine.

[54]  L. van de Putte,et al.  Cryosectioning of undecalcified tissues for immunofluorescence. , 1979, Journal of immunological methods.

[55]  T. Cooke,et al.  Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. , 1975, Arthritis and rheumatism.

[56]  N. Zvaifler,et al.  The immunopathology of joint inflammation in rheumatoid arthritis. , 1973, Advances in immunology.